Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10368242rdf:typepubmed:Citationlld:pubmed
pubmed-article:10368242lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:10368242lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:10368242lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:10368242lifeskim:mentionsumls-concept:C0202220lld:lifeskim
pubmed-article:10368242pubmed:issue9lld:pubmed
pubmed-article:10368242pubmed:dateCreated1999-8-2lld:pubmed
pubmed-article:10368242pubmed:abstractTextTo determine whether the use of serum insulin-like growth factor 1 (IGF-1) levels is more efficient than serum prostate specific antigen (PSA) levels in predicting prostate cancer in patients undergoing prostatic biopsy.lld:pubmed
pubmed-article:10368242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10368242pubmed:languageenglld:pubmed
pubmed-article:10368242pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10368242pubmed:citationSubsetIMlld:pubmed
pubmed-article:10368242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10368242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10368242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10368242pubmed:statusMEDLINElld:pubmed
pubmed-article:10368242pubmed:monthJunlld:pubmed
pubmed-article:10368242pubmed:issn1464-4096lld:pubmed
pubmed-article:10368242pubmed:authorpubmed-author:BlancJ LJLlld:pubmed
pubmed-article:10368242pubmed:authorpubmed-author:HuntCClld:pubmed
pubmed-article:10368242pubmed:authorpubmed-author:NisbetJ AJAlld:pubmed
pubmed-article:10368242pubmed:authorpubmed-author:KirbyR SRSlld:pubmed
pubmed-article:10368242pubmed:authorpubmed-author:DalgleishA...lld:pubmed
pubmed-article:10368242pubmed:authorpubmed-author:CuttingC WCWlld:pubmed
pubmed-article:10368242pubmed:issnTypePrintlld:pubmed
pubmed-article:10368242pubmed:volume83lld:pubmed
pubmed-article:10368242pubmed:ownerNLMlld:pubmed
pubmed-article:10368242pubmed:authorsCompleteYlld:pubmed
pubmed-article:10368242pubmed:pagination996-9lld:pubmed
pubmed-article:10368242pubmed:dateRevised2006-7-18lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:meshHeadingpubmed-meshheading:10368242...lld:pubmed
pubmed-article:10368242pubmed:year1999lld:pubmed
pubmed-article:10368242pubmed:articleTitleSerum insulin-like growth factor-1 is not a useful marker of prostate cancer.lld:pubmed
pubmed-article:10368242pubmed:affiliationSt George's Hospital, Department of Urology, St. George's Hospital Medical School, London, UK.lld:pubmed
pubmed-article:10368242pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10368242lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10368242lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10368242lld:pubmed